1. Home
  2. GRI vs EEIQ Comparison

GRI vs EEIQ Comparison

Compare GRI & EEIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

HOLD

Current Price

$2.25

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Logo EpicQuest Education Group International Limited

EEIQ

EpicQuest Education Group International Limited

HOLD

Current Price

$3.34

Market Cap

3.4M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRI
EEIQ
Founded
2018
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.4M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
GRI
EEIQ
Price
$2.25
$3.34
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$160.00
N/A
AVG Volume (30 Days)
41.3K
243.5K
Earning Date
05-15-2026
01-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.15
52 Week High
$6.70
$12.70

Technical Indicators

Market Signals
Indicator
GRI
EEIQ
Relative Strength Index (RSI) 58.28 50.14
Support Level $2.07 $2.52
Resistance Level $2.40 $3.65
Average True Range (ATR) 0.14 0.66
MACD 0.04 0.07
Stochastic Oscillator 93.42 30.25

Price Performance

Historical Comparison
GRI
EEIQ

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S, Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. The Company's revenue is derived from foreign education programs, university education programs and student accommodation services.

Share on Social Networks: